BlackRock Health Sciences Term Trust
BMEZ- Exchange
- NYSE
- SEC CIK
- 0001785971
No open-market purchases or sales by BlackRock Health Sciences Term Trust insiders were filed in the last 90 days; 87 institutions reported holding it in 13F filings for Q2 2026, worth $255.0M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in BlackRock Health Sciences Term Trust as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 102
- +12 vs. Q3 2024
- Shares held
- 44.1M
- −505.5K (−1.1%) vs. Q3 2024
- Total value
- $635.8M
- −$71.5M (−10.1%) vs. Q3 2024
- New holders
- 24
- 28 more added
- Sold out
- 12
- 36 more reduced
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BMEZ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 87 | $255.0M |
| Q1 2026 | 87 | $215.0M |
| Q4 2025 | 86 | $205.6M |
| Q3 2025 | 76 | $158.6M |
| Q2 2025 | 75 | $142.4M |
| Q1 2025 | 99 | $643.2M |
| Q4 2024 | 102 | $635.8M |
| Q3 2024 | 92 | $719.6M |
| Q2 2024 | 94 | $722.8M |
| Q1 2024 | 99 | $710.3M |
| Q4 2023 | 106 | $584.4M |
| Q3 2023 | 98 | $447.9M |
| Q2 2023 | 92 | $479.4M |
| Q1 2023 | 85 | $461.9M |
| Q4 2022 | 82 | $406.0M |
| Q3 2022 | 75 | $336.2M |
| Q2 2022 | 78 | $355.4M |
| Q1 2022 | 68 | $405.4M |
| Q4 2021 | 71 | $467.8M |
| Q3 2021 | 67 | $510.7M |
| Q2 2021 | 69 | $532.8M |
| Q1 2021 | 65 | $476.4M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding BlackRock Health Sciences Term Trust; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 3,173,373 | $45.7M | 0.00% | −244,292−7.1% | Reduced |
| Saba Capital Management, L.P. | 20,750,913 | $298.8M | 7.51% | +89,523+0.4% | Added |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −197,764−100.0% | Sold out |
| Transcend Wealth Collective, LLC | 0 | $0 | 0.00% | −36,357−100.0% | Sold out |
| NWF Advisory Services Inc. | 0 | $0 | 0.00% | −24,899−100.0% | Sold out |
| CNH Partners LLC | 0 | $0 | 0.00% | −16,631−100.0% | Sold out |
| Nova R Wealth, Inc. | 0 | $0 | 0.00% | −14,273−100.0% | Sold out |
| Corrado Advisors, LLC | 0 | $0 | 0.00% | −10,413−100.0% | Sold out |
| Chilton Capital Management LLC | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| Brown Brothers Harriman & Co | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Gilliland Jeter Wealth Management LLC | 0 | $0 | 0.00% | −658−100.0% | Sold out |
| Legacy Investment Solutions, LLC | 0 | $0 | 0.00% | −45−100.0% | Sold out |
| Legacy Wealth Managment, LLC | 0 | $0 | 0.00% | −45−100.0% | Sold out |
| Raymond James & Associates | – | – | – | – | Not filed |
| Raymond James Financial Services Advisors, Inc. | – | – | – | – | Not filed |